Reactivation of Graves' Orbitopathy after Rehabilitative Orbital Decompression

Ophthalmology

Volumn 114, Issue 7, 2007, Pages 1395-1402

  Baldeschi, Lelio ^a   Lupetti, Antonella ^b   Vu, Phung ^a   Wakelkamp, Iris M M J ^a   Prummel, Mark F ^a   Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; LEVOTHYROXINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; ARTICLE; CASE REPORT; CONVALESCENCE; DECOMPRESSION SURGERY; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; FEMALE; FOLLOW UP; GOITER; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; ORBIT; ORBIT DISEASE; ORBIT RADIOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; SURGICAL APPROACH; TREATMENT OUTCOME;

AGED; DECOMPRESSION, SURGICAL; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; METHYLPREDNISOLONE; MIDDLE AGED; ORBIT; PREDNISONE; RADIOTHERAPY; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347256358     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.10.036     Document Type: Article

References (22)

1. Rundle F.F., and Wilson C.W. Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clin Sci 5 (1945) 177-194
2. Prummel M.F., Wiersinga W.M., Mourits M.P., et al. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 150 (1990) 1098-1101
3. Prummel M.F., Mourits M.P., Berghout A., et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med 321 (1989) 1353-1359
4. Bartalena L., Pinchera A., and Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 21 (2000) 168-199
5. Wakelkamp I.M., Baldeschi L., Saeed P., et al. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy?. A randomized controlled trial. Clin Endocrinol (Oxf) 63 (2005) 323-328
6. Wenz R., Levine M.R., Putterman A., et al. Extraocular muscle enlargement after orbital decompression for Graves' ophthalmopathy. Ophthal Plast Reconstr Surg 10 (1994) 34-41
7. Werner S.C. Modifications of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. [letter]. J Clin Endocrinol Metab 44 (1977) 203-204
8. Mourits M.P., Prummel M.F., Wiersinga W.M., and Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 47 (1997) 9-14
9. Mourits M.P., Koornneef L., Wiersinga W.M., et al. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 73 (1989) 639-644
10. Wall J.R., Salvi M., Bernard N.F., et al. Thyroid-associated ophthalmopathy: a model for the association of organ-specific autoimmune disorders. Immunol Today 12 (1991) 150-153
11. + T-cell responses. Immunol Today 17 (1996) 410-414
12. Noelle R.J. CD40 and its ligand in host defense. Immunity 4 (1996) 415-419
13. Sempowski G.D., Rozenblit J., Smith T.J., and Phipps R.P. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol 274 (1998) C707-C714
14. Cao H.J., Wang H.S., Zhang Y., et al. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem 273 (1998) 29615-29625
15. 2 production in human lung fibroblasts. J Immunol 160 (1998) 1053-1057
16. + cytotoxic T lymphocyte priming capacity upon activation by T helper-independent or -dependent stimuli. J Exp Med 192 (2000) 145-150
17. - subpopulations exhibit distinct phenotypes. Eur J Immunol 32 (2002) 477-485
18. Shimojo N., Kohno Y., Yamaguchi K., et al. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci U S A 93 (1996) 11074-11079
19. Vaidya B., Imrie H., Perros P., et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. [letter]. Lancet 354 (1999) 743-744
20. Wai D.C., Ho S.C., Seah L.L., et al. Severe Graves' ophthalmopathy after retrobulbar anesthesia for cataract extraction in a patient with mild stable thyroid eye disease. Thyroid 13 (2003) 823-826
21. Rapoport B., Alsabeh R., Aftergood D., and McLachlan S.M. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 10 (2000) 685-692
22. Hamed L.M., and Lingua R.W. Thyroid eye disease presenting after cataract surgery. J Pediatr Ophthalmol Strabismus 27 (1990) 10-15